Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-03-16, Stock:NVS, The news for the past five days is as follows:
2018-03-09: NEWS1: How AstraZeneca’s Revenues Trended in 4Q17.NEWS2: The Swiss Stock Market Finished Higher After U.S. Jobs Report.NEWS3: The Swiss Stock Market Finished Higher After U.S. Jobs Report.
2018-03-12: NEWS1: How AstraZeneca’s Respiratory Products Performed in 4Q17.NEWS2: The Swiss Stock Market Is Approaching The 9,000 Point Level.NEWS3: The Swiss Stock Market Is Approaching The 9,000 Point Level.NEWS4: How AstraZeneca’s Business Segments Performed in 4Q17.NEWS5: Novartis CEO Narasimhan remakes drugmaker's leadership as Wyss exits.NEWS6: Novartis says operations head Wyss resigning, names three to executive panel.
2018-03-13: NEWS1: How Novartis’s Revenues Trended in 4Q17.NEWS2: What’s Novartis’s Valuation in March 2018?.NEWS3: How AstraZeneca’s Other Products Portfolio Performed in 4Q17.NEWS4: The Swiss Stock Market Dropped Following Afternoon Sell-Off.NEWS5: The Swiss Stock Market Dropped Following Afternoon Sell-Off.
2018-03-14: NEWS1: Why Intellia Therapeutics Is Plunging Today.NEWS2: Why Intellia Therapeutics Is Plunging Today.NEWS3: Why Intellia Therapeutics Is Plunging Today.NEWS4: How Novartis’s Sandoz Performed in 4Q17.NEWS5: Cancer Space Takes Giant Strides: Are Patients Benefiting?.NEWS6: Cancer Space Takes Giant Strides: Are Patients Benefiting?.NEWS7: The Swiss Stock Market Dipped On Disappointing U.S. Data.NEWS8: The Swiss Stock Market Dipped On Disappointing U.S. Data.NEWS9: Novartis’s Innovative Medicines Business in 4Q17.NEWS10: What Analysts Recommend for AstraZeneca in March 2018.NEWS11: Cancer Space Takes Giant Strides: Are Patients Benefiting?.NEWS12: How Novartis’s Business Segments Performed in 4Q17.NEWS13: What Analysts Expect for AstraZeneca Going Forward.
2018-03-15: NEWS1: Why Akcea Therapeutics, Inc. Is Soaring While Ionis Pharmaceuticals Is Dropping.NEWS2: Why Akcea Therapeutics, Inc. Is Soaring While Ionis Pharmaceuticals Is Dropping.NEWS3: What Analysts Recommend for Novartis in March 2018.NEWS4: How Pfizer Plans to Move Into the Big Leagues for Cancer Treatment.NEWS5: How Pfizer Plans to Move Into the Big Leagues for Cancer Treatment.NEWS6: Must-Know Recent Developments from Novartis.NEWS7: How Novartis’s Alcon Performed in 4Q17.NEWS8: Swiss Pharma Gets a Taste of Silicon Valley.

Answer: Rise